Novel homozygous deletions of chromosomal band 18q22 in pancreatic adenocarcinoma identified by STS marker scanning

Genes Chromosomes and Cancer

Volumn 25, Issue 4, 1999, Pages 370-375

  Hilgers, Werner ^a   Su, Gloria H ^a   Koerkamp, Bas Groot ^a   Tang, David J ^a   Shekher, Manu C ^a   Sugar, Avrahom Y ^a   Yeo, Charles J ^a   Hruban, Ralph H ^a   Kern, Scott E ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 18; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME DELETION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MAPPING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SEQUENCE TAGGED SITE; TUMOR SUPPRESSOR GENE;

EID: 0032794585     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199908)25:4<370::AID-GCC9>3.0.CO;2-S     Document Type: Article

References (19)

1. Barton CM, McKie AB, Hogg A, Bia B, Elia G, Phillips SM, Ding SF, Lemoine NR. 1995. Abnormalities of the RB1 and DCC tumor suppressor genes: uncommon in human pancreatic adenocarcinoma. Mol Carcinog 13:61-69.
2. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SK. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics 8:27-31.
3. Chen PL, Chen YM, Bookstein R, Lee WH. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576-1580.
4. Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tom P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M, Birren BB, Browne J, Butler A, Castle AB, Chiannilkulchai N, Clee C, Day PJR, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C, Fox S. Gelling S, Green L, Harrison P, Hocking R, Holloway F, Hunt S, Keil S, Lijnzaad P, Louis-Dit-Sully C, Ma J, Mendis A, Miller J, Morissette J, Muselet D, Nusbaum HC, Peck A, Rozen S, Simon D, Slonim DK, Staples R, Stein LD, Stewart EA, Suchard MA, Thangarajah T, Vega-Czarny N. 1998. A physical map of 30,000 human genes. Science 282:744-746.
5. Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE. 1998. Genetic alterations of the TGF-beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58:5329-5332.
6. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1995. Allelotype of pancreatic adenocarcinoma using a xenograft model. Cancer Res 55:4670-4675.
7. Hahn SA, Hoque ATMS, Moskaluk CA, daCosta LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE. 1996a. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494.
8. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996b. DPC4, a candidate tumor-suppressor gene at 18q21.1. Science 271:350-353.
9. Hilgers W, Tang DJ, Shekher MC, Hruban RJ, Kern SE. 1998. Pancreatic Ca homozygous deletions at D9S126 overlap the p16 gene. NOGO 2:24.
10. Jen J, Kim H, Piantadosi S, Liu Z-F, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR. 1994. Allelic loss of chromosome 18q and prognosis of colorectal cancer. N Engl J Med 331:213-221.
11. Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton SR. 1989. Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 261:3099-3103.
12. Moats-Staats BM, Jarvis JW, D'Ercole AJ, Stiles AD. 1994. Cloning and characterization of a novel RNA involved in cellular growth regulation. Mol Cell Biol 14:2936-2945.
13. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA, Dyke DL. 1998. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21:333-339.
14. Riggins GJ, Thiagalingam S, Goggins M, Kern SE, Kinzler KW, Vogelstein B. 1997. Normal SMAD2 gene in pancreatic cancer. NOGO 1:40.
15. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque ATMS, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE. 1995. A homozygous deletion identified by representational difference analysis in pancreatic carcinoma overlaps the BRCA2 region. Proc Natl Acad Sci USA 92:5950-5954.
16. Silverman GA. 1993. Isolating vector-insert junctions from yeast artificial chromosomes. PCR Meth Appl 3:141-150.
17. Su GH, Hilgers W, Shekher M, Tang D, Yeo CJ, Hruban RH, Kern SE. 1998. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor-suppressor gene. Cancer Res 58:2339-2342.
18. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC, Westerman AM, Entius MM, Goggins M, Yeo CJ, Kern SE. 1999. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (in press).
19. Teng DH-F, Perry III WL, Hogan JK, Baumgard M, Bell R, Berry S, Davis T, Frank D, Frye C, Hattier T, Hu R, Jammulapati S, Janecki T, Leavitt A, Mitchell JT, Pero R, Sexton D, Schroeder M, Su PJ, Swedlund B, Kyriakis JM, Avruch J, Bertel P, Wong AK, Tavtigian SV. 1997. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 57:4177-4182.